Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 766 AL 780

Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?

Duncan GW, Firbank MJ, O'Brien JT, Burn DJ.

Mov Disord. 2013 Apr;28(4):425-38. doi: 10.1002/mds.25352. Epub 2013 Feb 28.

Olfactory dysfunction: common in later life and early warning of neurodegenerative disease

Hüttenbrink KB, Hummel T, Berg D, Gasser T, Hähner A.

Dtsch Arztebl Int. 2013 Jan;110(1-2):1-7, e1. doi: 10.3238/arztebl.2013.0001. Epub 2013 Jan 7.

Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies

Schildknecht S, Gerding HR, Karreman C, Drescher M, Lashuel HA, Outeiro TF, Di Monte DA, Leist M.

J Neurochem. 2013 May;125(4):491-511. doi: 10.1111/jnc.12226. Epub 2013 Mar 19.

A patient with Parkinson's disease benefits from spinal cord stimulation

Hassan S, Amer S, Alwaki A, Elborno A.

J Clin Neurosci. 2013 Aug;20(8):1155-6. doi: 10.1016/j.jocn.2012.08.018. Epub 2013 Feb 26.

Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery

Müller T, van Laar T, Cornblath DR, Odin P, Klostermann F, Grandas FJ, Ebersbach G, Urban PP, Valldeoriola F, Antonini A.

Parkinsonism Relat Disord. 2013 May;19(5):501-7 ; discussion 501. doi: 10.1016/j.parkreldis.2013.02.006. Epub 2013 Feb 27.

Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia

Seeman P, Tinazzi M.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:178-83. doi: 10.1016/j.pnpbp.2013.02.011. Epub 2013 Feb 26.

Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases

Chavarría C, Souza JM.

Arch Biochem Biophys. 2013 May;533(1-2):25-32. doi: 10.1016/j.abb.2013.02.009. Epub 2013 Feb 27.

Current status of chemokines in the adult CNS

Réaux-Le Goazigo A, Van Steenwinckel J, Rostène W, Mélik Parsadaniantz S.

Prog Neurobiol. 2013 May;104:67-92. doi: 10.1016/j.pneurobio.2013.02.001. Epub 2013 Feb 27.

Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?

Chaudhuri KR, Rizos A, Sethi KD.

J Neural Transm (Vienna). 2013 Sep;120(9):1305-20. doi: 10.1007/s00702-013-0981-5. Epub 2013 Mar 2.

Centenary of Lewy bodies (1912-2012)

Holdorff B, Rodrigues e Silva AM, Dodel R.

J Neural Transm (Vienna). 2013 Apr;120(4):509-16. doi: 10.1007/s00702-013-0984-2. Epub 2013 Mar 2.

Phantosmia as a meteorological forecaster

Aiello SR, Hirsch AR.

Int J Biometeorol. 2013 Sep;57(5):813-5. doi: 10.1007/s00484-013-0639-x. Epub 2013 Mar 1.

Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, Weir D, Thompson C, Szu-Tu C, Trinh J, Aasly JO, Rajput A, Rajput AH, Jon Stoessl A, Farrer MJ.

Mov Disord. 2013 Jun;28(6):811-3. doi: 10.1002/mds.25421. Epub 2013 Mar 1.

A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models

Thai HT, Mentré F, Holford NH, Veyrat-Follet C, Comets E.

Pharm Stat. 2013 May-Jun;12(3):129-40. doi: 10.1002/pst.1561. Epub 2013 Mar 4.

Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial

van Nimwegen M, Speelman AD, Overeem S, van de Warrenburg BP, Smulders K, Dontje ML, Borm GF, Backx FJ, Bloem BR, Munneke M; ParkFit Study Group.

BMJ. 2013 Mar 1;346:f576. doi: 10.1136/bmj.f576.

Lessons for Parkinson disease from the parkin genotype

Ahlskog JE.

JAMA Neurol. 2013 May;70(5):551-2. doi: 10.1001/jamaneurol.2013.104.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias